Companion digital solutions can help users develop new behaviors to ensure theyve made a change that will stick for good. Marni Allen, CMO, Bioniq PepsiCo: Negligible impact At PepsiCo, so far at least, the impact of GLP-1 drugs has been negligible, CEO Ramon Laguarta told analysts during the firms latest earnings call
Product fit, availability, timing, and next steps should be reviewed with a qualified provider.
Blood work may be ordered to check markers tied to blood sugar, thyroid function, or other metabolic indicators
employers with 500 or more employees and 64% of employers with 20,000 or more workers cover them compared with 2023, according to Mercers annual survey of employer-sponsored health plans